普洛藥(yao)業股份有限公司是(shi)一家醫(yi)藥(yao)企(qi)業。2001年在深交所主板上市,是(shi)橫店集(ji)團(tuan)醫(yi)藥(yao)產業產融(rong)結合平臺。
公司從事醫(yi)藥(yao)產(chan)品的研發(fa)、生產(chan)和銷(xiao)售。主(zhu)要(yao)業(ye)(ye)務(wu)(wu)有原料藥(yao)(API)業(ye)(ye)務(wu)(wu)、合同(tong)研發(fa)生產(chan)服務(wu)(wu)(CDMO)業(ye)(ye)務(wu)(wu)和制劑(ji)(FDF)業(ye)(ye)務(wu)(wu),產(chan)品主(zhu)要(yao)集中在心腦血管、抗感染(ran)、抗腫瘤等治療領域。目(mu)前(qian),原料規模化(hua)生產(chan)品種(zhong)70余個,銷(xiao)售過億品種(zhong)有11個,羥酸、安非、沙坦(tan)、D-乙(yi)酯等品種(zhong)占全球市(shi)場絕對份額。
公(gong)司總部(bu)位于浙(zhe)(zhe)江省東(dong)陽(yang)市(shi)橫(heng)店鎮,有7家原料藥生產工廠和4家制劑生產工廠,分(fen)布在(zai)浙(zhe)(zhe)江橫(heng)店、浙(zhe)(zhe)江衢州、山東(dong)濰坊、安徽池(chi)州、山西(xi)大同等地(di);在(zai)公(gong)司總部(bu)以(yi)及上海、成(cheng)都、杭州設(she)立了研發(fa)機構(gou);在(zai)美國、香港設(she)立了境外公(gong)司或分(fen)支機構(gou)。
為確立市場(chang)競(jing)爭(zheng)優勢(shi),公司(si)(si)持續打造質量、EHS和(he)技術核心競(jing)爭(zheng)力。原料藥工(gong)(gong)廠有(you)5家(jia)通(tong)(tong)(tong)過(guo)(guo)(guo)GMP認(ren)(ren)(ren)證(zheng),有(you)4 家(jia)通(tong)(tong)(tong)過(guo)(guo)(guo)FDA認(ren)(ren)(ren)證(zheng),3家(jia)通(tong)(tong)(tong)過(guo)(guo)(guo)PMDA認(ren)(ren)(ren)證(zheng),3家(jia)通(tong)(tong)(tong)過(guo)(guo)(guo)歐(ou)盟CE認(ren)(ren)(ren)證(zheng),1家(jia)通(tong)(tong)(tong)過(guo)(guo)(guo)世衛(wei)組織WHO認(ren)(ren)(ren)證(zheng),1家(jia)通(tong)(tong)(tong)過(guo)(guo)(guo)KFDA認(ren)(ren)(ren)證(zheng),1家(jia)通(tong)(tong)(tong)過(guo)(guo)(guo)德國(guo)GMP認(ren)(ren)(ren)證(zheng);制劑工(gong)(gong)廠均(jun)通(tong)(tong)(tong)過(guo)(guo)(guo)GMP認(ren)(ren)(ren)證(zheng)。原料藥工(gong)(gong)廠除通(tong)(tong)(tong)過(guo)(guo)(guo)安全與(yu)職業健(jian)康管理體系認(ren)(ren)(ren)證(zheng)外,還不斷接受并通(tong)(tong)(tong)過(guo)(guo)(guo)國(guo)際制藥公司(si)(si)或第(di)三方的EHS審計。
公司秉持“共創、共有、共富、共享”的(de)核心價(jia)值,著力打造“快(kuai)樂(le)學習、快(kuai)樂(le)運動、快(kuai)樂(le)工(gong)作”的(de)芒果视(shi)频,實施“做(zuo)精原料、做(zuo)強CDMO、做(zuo)優制劑”的(de)發(fa)展戰略,以文化(hua)推(tui)動創新,以創新驅動未來。愿與社(she)會各界攜手,為實現“健康(kang)夢(meng)”做(zuo)出更大貢獻。